Ebola vaccine trial starts in eastern Congo amid ongoing outbreak

A technical trial of an Ebola vaccine has begun in eastern Democratic Republic of Congo, where the outbreak has caused 9,704 confirmed cases and 4,687 deaths as of October 20. The trial represents a new phase in the response, though efficacy and deployment details remain unclear. The high case fatality rate underscores the urgency of the intervention.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works